Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well...

Full description

Saved in:
Bibliographic Details
Main Authors REEL JON K, DROSTE JAMES J, BRITTON THOMAS C, HENRY STEVEN S, CWI CYNTHIA L, WU JING, AUDIA JAMES A, MABRY THOMAS E, STUCKY RUSSELL D, TUNG JAY S, PORTER WARREN J, THORSETT EUGENE D, LATIMER LEE H, PLEISS MICHAEL A, NEITZ R. J, DRESSMAN BRUCE A, NISSEN JEFFREY S, MCDANIEL STACEY L, JOHN VARGHESE, FREEDMAN STEPHEN, SCOTT WILLIAM L
Format Patent
LanguageEnglish
Published 15.09.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
Bibliography:Application Number: US20030733877